Summary
This filing is an amendment to Cigna Group's (CI) Form 8-K filed on December 20, 2018, concerning the completion of its merger with Express Scripts. The primary purpose of this amendment is to provide the necessary financial statements and pro forma financial information related to the acquired Express Scripts business. Investors should note that this filing does not contain new operational or strategic updates but rather supplements the previous report with detailed historical financial data of Express Scripts and pro forma combined financial information. This information is crucial for understanding the financial complexion of the combined entity post-merger.
Key Highlights
- 1Amendment to Cigna's December 20, 2018 8-K filing to provide required financial statements and pro forma information.
- 2Completion of the merger between Cigna Corporation and Express Scripts Holding Company occurred on December 20, 2018.
- 3Incorporates audited consolidated financial statements for Express Scripts for the years ended December 31, 2017, 2016, and 2015.
- 4Includes unaudited consolidated financial statements for Express Scripts for the periods ending September 30, 2018, and related prior periods.
- 5Provides unaudited pro forma combined financial information for the nine months ended September 30, 2018, and the year ended December 31, 2017.
- 6This filing serves to fulfill regulatory requirements by supplying detailed financial data of the acquired entity and projected combined results.
Frequently Asked Questions
This filing is an amendment to a previous 8-K report to provide the audited and unaudited financial statements of Express Scripts, the acquired company, and pro forma combined financial information, as required by SEC regulations following the completion of the merger.
No, this filing is purely informational and focuses on providing historical financial data for Express Scripts and pro forma combined financial statements. It does not contain new strategic updates or operational commentary from Cigna.
The audited consolidated financial statements for Express Scripts for the years ended December 31, 2017, 2016, and 2015, as well as unaudited statements for periods ending September 30, 2018, are included as Exhibits 99.1 and 99.2 to this Form 8-K/A.
Pro forma combined financial information presents hypothetical combined financial statements of Cigna and Express Scripts as if the merger had occurred at an earlier point in time. This information is for illustrative purposes and helps investors understand the potential financial scale and structure of the combined company.